Vibrio Vulnificus: A Hidden Death Toll from Hurricane Helene
Hurricane Helene's direct death toll of 12 in Pinellas County is dwarfed by an additional 5 deaths from Vibrio vulnificus infections in the following weeks, highlighting the undercounting of hurricane-related fatalities due to climate change's impact on bacterium outbreaks and the increasing intensi...
Vibrio Vulnificus: A Hidden Death Toll from Hurricane Helene
Hurricane Helene's direct death toll of 12 in Pinellas County is dwarfed by an additional 5 deaths from Vibrio vulnificus infections in the following weeks, highlighting the undercounting of hurricane-related fatalities due to climate change's impact on bacterium outbreaks and the increasing intensi...
Progress
20% Bias Score
AI Tool Detects Early Dementia Signs from Retinal Scans
Scottish researchers developed an AI tool using almost a million eye scans to detect early dementia signs from retinal photographs, aiming for wider rollout to opticians by 2026, improving early diagnosis and patient outcomes.
AI Tool Detects Early Dementia Signs from Retinal Scans
Scottish researchers developed an AI tool using almost a million eye scans to detect early dementia signs from retinal photographs, aiming for wider rollout to opticians by 2026, improving early diagnosis and patient outcomes.
Progress
40% Bias Score
EU Bans Bisphenol A from Food Contact Materials
The European Union banned Bisphenol A (BPA) from all food contact materials starting January 20, 2024, following a 2023 EFSA opinion citing health risks across all ages; the ban, years in the making, includes containers, bottles, and coatings, and may extend to other consumer products.
EU Bans Bisphenol A from Food Contact Materials
The European Union banned Bisphenol A (BPA) from all food contact materials starting January 20, 2024, following a 2023 EFSA opinion citing health risks across all ages; the ban, years in the making, includes containers, bottles, and coatings, and may extend to other consumer products.
Progress
36% Bias Score
Edinburgh Maternity Unit Review Highlights Staffing Shortages and Patient Harm
A review into the care of baby Roddy, who suffered brain damage during labor at Edinburgh Royal Infirmary, found multiple missed opportunities for observation and treatment due to short-staffing and a "toxic" work culture, resulting in a five-to-six-hour delay in crucial interventions.
Edinburgh Maternity Unit Review Highlights Staffing Shortages and Patient Harm
A review into the care of baby Roddy, who suffered brain damage during labor at Edinburgh Royal Infirmary, found multiple missed opportunities for observation and treatment due to short-staffing and a "toxic" work culture, resulting in a five-to-six-hour delay in crucial interventions.
Progress
48% Bias Score
France's Early COVID-19 Response: Internal Communications Reveal Critical Failures
On January 22, 2020, a Chinese patient hospitalized in Paris with a high fever triggered internal discussions within the French Ministry of Health, revealing concerns about the lack of equipment for airport screening and highlighting the significant challenge posed by the numerous flights between Wu...
France's Early COVID-19 Response: Internal Communications Reveal Critical Failures
On January 22, 2020, a Chinese patient hospitalized in Paris with a high fever triggered internal discussions within the French Ministry of Health, revealing concerns about the lack of equipment for airport screening and highlighting the significant challenge posed by the numerous flights between Wu...
Progress
40% Bias Score
Weight-Loss Drugs Show Reduced Alzheimer's Risk, But Increased Gastrointestinal Issues
A study of over two million US diabetic patients found that GLP-1 receptor agonist weight-loss drugs like Wegovy and Ozempic reduced the risk of Alzheimer's by 12%, drug/alcohol dependence, and some blood clotting issues, but increased risks of gastrointestinal problems, low blood pressure, and kidn...
Weight-Loss Drugs Show Reduced Alzheimer's Risk, But Increased Gastrointestinal Issues
A study of over two million US diabetic patients found that GLP-1 receptor agonist weight-loss drugs like Wegovy and Ozempic reduced the risk of Alzheimer's by 12%, drug/alcohol dependence, and some blood clotting issues, but increased risks of gastrointestinal problems, low blood pressure, and kidn...
Progress
32% Bias Score
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes revealed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues, including cardiovascular problems and infections, but increased risks of gastrointestinal issues and low blood pressure.
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes revealed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues, including cardiovascular problems and infections, but increased risks of gastrointestinal issues and low blood pressure.
Progress
40% Bias Score
Reproductive Rights Website Offline After Trump Inauguration
The U.S. Department of Health and Human Services' reproductive rights website, reproductiverights.gov, went offline around President Trump's inauguration, raising concerns given its role in providing information on abortion access and reproductive healthcare.
Reproductive Rights Website Offline After Trump Inauguration
The U.S. Department of Health and Human Services' reproductive rights website, reproductiverights.gov, went offline around President Trump's inauguration, raising concerns given its role in providing information on abortion access and reproductive healthcare.
Progress
48% Bias Score
GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed
A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.
GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed
A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.
Progress
36% Bias Score
EU Bans Bisphenol A in Food Contact Materials
The European Union banned Bisphenol A (BPA) in all food-contact materials starting January 20, 2024, following concerns about its endocrine-disrupting properties and links to health issues like breast cancer and diabetes; the ban, years in the making, covers various products including cans, containe...
EU Bans Bisphenol A in Food Contact Materials
The European Union banned Bisphenol A (BPA) in all food-contact materials starting January 20, 2024, following concerns about its endocrine-disrupting properties and links to health issues like breast cancer and diabetes; the ban, years in the making, covers various products including cans, containe...
Progress
28% Bias Score
High Blood Pressure and Diabetes Prevalence and Prevention in the US
Approximately half of US adults have high blood pressure, and over 10% have diabetes, significantly increasing heart disease and stroke risks; early diagnosis and treatment, even without symptoms, are crucial, with lifestyle changes and medications offering effective management.
High Blood Pressure and Diabetes Prevalence and Prevention in the US
Approximately half of US adults have high blood pressure, and over 10% have diabetes, significantly increasing heart disease and stroke risks; early diagnosis and treatment, even without symptoms, are crucial, with lifestyle changes and medications offering effective management.
Progress
16% Bias Score
EU Bans Bisphenol A in All Food Contact Materials
The European Union banned Bisphenol A (BPA) from all food contact materials starting January 20, 2024, due to health concerns identified by the European Food Safety Authority (EFSA), following over a decade of scientific warnings and a prior ban on its use in products for infants and young children.
EU Bans Bisphenol A in All Food Contact Materials
The European Union banned Bisphenol A (BPA) from all food contact materials starting January 20, 2024, due to health concerns identified by the European Food Safety Authority (EFSA), following over a decade of scientific warnings and a prior ban on its use in products for infants and young children.
Progress
44% Bias Score